<DOC>
	<DOCNO>NCT00503035</DOCNO>
	<brief_summary>Primary Objective : - To determine whether celecoxib downregulates GATA-6 expression upregulate 15-LOX-1 expression induce apoptosis human rectal tumor , researcher measure GATA-6 15-LOX-1 expression , 13-S-HODE level , apoptosis rate normal colorectal polyp epithelial tissue 6 month celecoxib treatment patient familial adenomatous polyposis ( FAP ) .</brief_summary>
	<brief_title>Molecular Targeting 15-Lipoxygenase-1 ( 15-LOX-1 ) Apoptosis Induction Human Colorectal Cancers</brief_title>
	<detailed_description>Celecoxib drug develop treat arthritis . However , celecoxib may also help stop slow growth colon rectal tumor cell . At start study , ask question medical history , complete physical exam , around 2 tablespoon blood draw blood test part routine care familial adenomatous polyposis . Also , blood test fast blood glucose lipid profiling ( cholesterol , LDL , HDL triglyceride ) assess determine eligibility . Women able child must negative blood pregnancy test within 14 day start celecoxib . Before scheduled colonoscopy , fill form ask medication nutritional supplement take . In addition , ask complete diet history . This help researcher evaluate patient ' dietary habit . The questionnaire take 15 minute complete . You also around 1 teaspoon blood drawn measure amount celecoxib blood . Then , already schedule colonoscopy procedure , additional tissue biopsy ( size pencil tip ) colon take . For colonoscopy procedure , flexible tube light attach end use look inside colon/lower gut . The biopsy take flexible tube use special cut tool . Up 23 biopsy sample may take . The biopsy take 20 extra minute complete . After procedure , start take celecoxib mouth every 12 hour 6 month . You also around 1 teaspoon blood drawn measure amount celecoxib blood completion month 2 4 celecoxib treatment . At end 6 month treatment period , another colonoscopy procedure . This additional procedure perform solely study part standard care treatment familial adenomatous polyposis . A second set biopsy take ( 23 maximum ) . These biopsy sample study compare sample take treatment celecoxib . You also around 1 teaspoon blood drawn measure amount celecoxib blood . You contact phone 72 hour first dose celecoxib every 2 week study check side effect may experience . The maximum amount time remain study 6 month . If time , experience intolerable side effect , take study . This investigational study . Celecoxib FDA approve commercially available familial adenomatous polyposis patient reduce polyp formation . Up 40 patient take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>1 . Diagnosis familial adenomatous polyposis ( patient colorectal remnant biopsied . Patients total colorectal surgical resection eligible ) . 2 . Adequate bone marrow function ( ANC &gt; 1500 ml , platelet count &gt; 100,000/ml ) . Serum creatinine , total bilirubin , ALT &lt; 1.5 upper limit normal . 3 . Over 16 year age . 4 . Patient able give inform consent . 5 . Women childbearing potential ( woman consider childbearing potential unless 2 year postmenopausal/or surgically sterile ) , must : Not pregnant lactating . use adequate contraceptive measure ( abstinence , IUD , birth control pill , diaphragm condom spermicidal gel ) start last menses throughout study duration . Have negative serum pregnancy test within 14 day start celecoxib . 1 . Inflammatory bowel disease . 2 . Intake antiinflammatory medication ( e.g. , nonsteroidal , aspirin , sulfasalazine ) discontinue start 3 day prior enrollment . 3 . Chemotherapy radiation therapy less three month time enrollment . 4 . Individuals take Coumadin discontinue start 7 day prior enrollment . 5 . Individuals receive investigational chemopreventive agent month prior biopsy . 6 . History bleed diathesis . 7 . History sulfonamide ( sulfa ) allergy . 8 . History cardiovascular disease might include follow : myocardial infarction , angina , coronary angioplasty , congestive heart failure , stroke , coronary bypass surgery . 9 . Uncontrolled hypertension ( &gt; 135/ &gt; 85 mm Hg three repeat measurement 6 week prior enrollment study ) . 10 . Diagnosis diabetes . 11 . Smoking history 6 month prior enrollment study . 12 . Uncontrolled hypercholesteremia ( lowdensity lipoprotein cholesterol ( LDLC ) &gt; 130 ) . Hypercholesteremia need control follow updated National Cholesterol Education Program Adult Treatment Panel III Guidelines least 3 month prior enrollment study . Hypercholesteremia treatment need continue enrollment protocol . 13 . Family history premature coronary disease ( i.e. , onset &lt; 55 year age ) . 14 . Metabolic syndrome diagnosis patient 30 year old . ( The diagnosis metabolic syndrome make three risk factor present ) : Waist circumference : Men &gt; 102 cm ( &gt; 40 ) ; Women &gt; 88 cm ( &gt; 35 ) . *Triglycerides = 150 mg/dl ( = 1.69 mmol/L ) . Highdensity lipoprotein cholesterol ( HDLC ) : [ Men &lt; 40 mg/dl ( &lt; 1.03 mmol/L ) , Women &lt; 50 mg/dl ( &lt; 1.29 mmol/L ) ] . Blood pressure = 130/= 85 mm Hg . Fasting glucose = 110 mg/dl ( = 6.1 mmol/L ) . 15 . History deep venous thrombosis , pulmonary embolism , systemic lupus erythematous , family history protein S C deficiencies prior heparininduced thrombocytopenia .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Familial Adenomatous Polyposis</keyword>
	<keyword>Colorectal Tumors</keyword>
	<keyword>Molecular Targeting</keyword>
	<keyword>Celecoxib</keyword>
	<keyword>Celebrex</keyword>
	<keyword>SC-58635</keyword>
	<keyword>Apoptosis Induction</keyword>
	<keyword>Colon</keyword>
	<keyword>Rectum</keyword>
	<keyword>colonoscopy</keyword>
	<keyword>Biopsy</keyword>
</DOC>